市場調查報告書

耳朵感染疾病治療市場 - 成長,趨勢,預測

Ear Infection Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921253
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
耳朵感染疾病治療市場 - 成長,趨勢,預測 Ear Infection Treatment Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 111 Pages
簡介

組合香煙的煙和吸煙者吐出的煙的話,增加空氣中尼古丁和其他毒素等不健康的粒子。這增加微生物的成長,增加耳朵感染的風險。

本報告提供耳朵感染疾病治療的世界市場調查,市場概要,各類型、用途、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭加劇

第5章 市場區隔

  • 各感染疾病
    • 內耳感染
    • 中耳感染
    • 外耳感染
  • 各原因
    • 病毒感染
    • 細菌感染
  • 各類型
    • 手術
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Olympus Corporation
    • American Diagnostic Corporation
    • Pfizer plc
    • Novartis
    • Grace Medical
    • Sanofi SA
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Cipla Ltd

第7章 市場機會及未來趨勢

目錄
Product Code: 67162

Market Overview

An ear infection occurs when a bacterial or viral infection affects the inner, middle or outer ear. Ear infections can be painful because of inflammation and fluid buildup in the ear. An acute ear infection can cause mild pain and discomfort in the ear. However chronic cases can cause severe pain, loss of body balance, drainage of fluids from the ear, headache and even hearing the loss in some cases.

Smoke from a burning cigarette combined with exhaled smoke from a person who smokes increases unhealthy particles in the air, including those of nicotine and other toxins. This increases the microbe growth in such households, which increases the risk of ear infection. This is the major driving factor for the growth of this market. Other factors like unclean and unhealthy environments also increase the risk of ear infection, which leads to the growth of the ear infection treatment market.

However high cost of surgical procedures in severe cases has been restraining the growth of this market.

Scope of the Report

Ear Infection treatment involves medication and surgeries that help to treat and eliminate the infection from the infected area.

In the report, a detailed analysis of the ear Infection treatment market is provided. The market is evaluated by collating revenues generated across segments, categorized by infection, cause, type, and geography.

Key Market Trends

Treatment for Middle ear infection is expected to cover a larger share of the market.

Middle ear infection also referred to as otitis media, is the most common ear infection, especially in children. According to a study by Kaur R et al. published Pediatric Journal 2017, by 1 year of age, 23% of the children experienced more than one episode of acute otitis media (AOM). By 3 years of age, 60% had more than one episode of AOM, and nearly 24% had more than 3 such episodes. The peak incidence was reported to have occurred at 6 to 12 months of life.

As can be noted, the prevalence is very high for children. Hence requirement immediate treatment is very necessary. Thus, this treatment for a middle ear infection is expected to occupy a large share of the market.

North America dominates the market

According to an article by Kaur R et al. published Pediatric Journal 2017, over 5 million acute otitis media (AOM) cases occur annually in US children, resulting in more than 10 million annual antibiotic prescriptions and an estimated 30 million annual visits for medical care. AOM is also the most common condition treated with antibiotics in the US. As per the article, increasing the incidence of antibiotic resistance among the organisms responsible for AOM is a cause for concern.

However, the US has a developed and structured healthcare system that encourages research and development among pharmaceutical companies and various research organizations. The healthcare system is also involved in spreading awareness regarding the treatment, which increases its demand. Hence, this region is expected to dominate the market.

Competitive Landscape

The majority of the key player involved in research and manufacturing of Ear Infection Treatment are established in developed countries. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market growth.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Exposure to Smoke
    • 4.2.2 Unclean and Unhealthy Surroundings
  • 4.3 Market Restraints
    • 4.3.1 High Cost and Complications related Surgical procedures
    • 4.3.2 Growing Incidents of Drug Resistance
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Infection
    • 5.1.1 Inner Ear Infection
    • 5.1.2 Middle Ear Infection
    • 5.1.3 Outer Ear Infection
  • 5.2 By Cause
    • 5.2.1 Viral Infection
    • 5.2.2 Bacterial Infection
  • 5.3 By Type
    • 5.3.1 Medication
      • 5.3.1.1 Antibiotics
      • 5.3.1.2 Analgesics
      • 5.3.1.3 AntiViral
    • 5.3.2 Surgery
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Olympus Corporation
    • 6.1.2 American Diagnostic Corporation
    • 6.1.3 Pfizer plc
    • 6.1.4 Novartis
    • 6.1.5 Grace Medical
    • 6.1.6 Sanofi S.A.
    • 6.1.7 GlaxoSmithKline plc
    • 6.1.8 Johnson & Johnson
    • 6.1.9 Cipla Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS